Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 25 (KRT8P25) is classified as a pseudogene, meaning it is a segment of DNA that resembles a functional gene but is generally non-functional and does not produce a functional protein product. Pseudogenes arise from gene duplications or retrotransposition events, and while they may share sequence similarity with their parent gene—in this case, keratin 8 (KRT8)—they do not have the same biological function. KRT8P25 is located on chromosome 3 (chr3:87323268-87324723, hg38). It has no established functional role, disease associations, or evidence of being a protein-coding region, receptor, enzyme, or other therapeutic target. There are no known drugs that interact with this pseudogene, nor does it serve as a biomarker or have known implications in safety or therapeutic challenge. It should not be confused with the functional gene KRT8, which encodes a type II keratin involved in the cytoskeletal structure of epithelial cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 25 (KRT8P25).